Your browser doesn't support javascript.
loading
Prospective study of gestational diabetes and fatty liver scores 9 to 16 years after pregnancy.
Donnelly, Sarah R; Hinkle, Stefanie N; Rawal, Shristi; Grunnet, Louise G; Chavarro, Jorge E; Vaag, Allan; Wu, Jing; Damm, Peter; Mills, James L; Li, Mengying; Bjerregaard, Anne A; Thuesen, Anne Cathrine B; Gore-Langton, Robert E; Francis, Ellen C; Ley, Sylvia H; Hu, Frank B; Tsai, Michael Y; Olsen, Sjurdur F; Zhang, Cuilin.
Afiliação
  • Donnelly SR; Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.
  • Hinkle SN; Department of Human Nutrition, Foods, and Exercise, Virginia Polytechnic Institute and State University, Blacksburg, Virginia.
  • Rawal S; Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.
  • Grunnet LG; Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.
  • Chavarro JE; Department of Nutritional Sciences, School of Health Professions, Rutgers University, Newark, New Jersey.
  • Vaag A; Department of Endocrinology, Diabetes and Metabolism, Rigshospitalet, Copenhagen, Denmark.
  • Wu J; The Danish Diabetes Academy, Odense, Denmark.
  • Damm P; Harvard T. H. Chan School of Public Health, Harvard University, Boston, Massachusetts.
  • Mills JL; Channing Division of Network Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts.
  • Li M; Cardiovascular and Metabolic Disease Translational Medicine Unit, Early Clinical Development, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Bjerregaard AA; Glotech, Rockville, Maryland.
  • Thuesen ACB; Center for Pregnant Women with Diabetes, Departments of Endocrinology and Obstetrics, Rigshospitalet, Copenhagen, Denmark.
  • Gore-Langton RE; Institute of Clinical Medicine, Faculty of Health and Medical Services, University of Copenhagen, Copenhagen, Denmark.
  • Francis EC; Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.
  • Ley SH; Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.
  • Hu FB; Centre for Fetal Programming, Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
  • Tsai MY; Department of Endocrinology, Diabetes and Metabolism, Rigshospitalet, Copenhagen, Denmark.
  • Olsen SF; The Emmes Corporation, Rockville, Maryland.
  • Zhang C; Epidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.
J Diabetes ; 11(11): 895-905, 2019 Nov.
Article em En | MEDLINE | ID: mdl-31001915
ABSTRACT

BACKGROUND:

Women with gestational diabetes mellitus (GDM) may be at an increased risk of liver complications because chronic hyperglycemia is a risk factor for liver fat accumulation and potential liver dysfunction. Large prospective studies examining liver fat accumulation following a GDM pregnancy are lacking.

METHODS:

The Diabetes & Women's Health Study (2012-2014) examined the association between GDM and subsequent fatty liver scores among 607 women with and 619 women without GDM in the Danish National Birth Cohort. Nine to 16 years postpartum, a clinical examination was performed, with measurement of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and γ-glutamyl transferase, from which fatty liver scoring indices were calculated to assess liver fat score, fatty liver index, hepatic steatosis index, and liver fat percentage. Relative risks (RR) with 95% confidence intervals (CI) for elevated liver scoring indices by GDM status were assessed adjusting for major risk factors, including prepregnancy body mass index.

RESULTS:

Women with prior GDM had higher adjusted ALT and AST levels than women without GDM (by 6.7% [95% CI 1.7-12.0] and 4.8% [95% CI 0.6-9.1], respectively). Women with GDM also had adjusted increased risks for elevated liver fat score (RR 2.34; 95% CI 1.68-3.27), fatty liver index (RR 1.59; 95% CI 1.27-1.99), and hepatic steatosis index (RR 1.44; 95% CI 1.21-1.71).

CONCLUSIONS:

Women with GDM during pregnancy were at an increased risk for fatty liver 9 to 16 years postpartum. Gestational diabetes mellitus may serve as another risk indicator for the early identification and prevention of liver fat accumulation.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Gestacional / Fígado Gorduroso Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Pregnancy País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Gestacional / Fígado Gorduroso Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Pregnancy País/Região como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article